.

ספרות מדעית - בדיקת AMAS

1. National Cancer Institute Monographs 46:133-137, 1977

2. Lancet 1:987, 1979

3. Lancet 2:141-142, 1981

4. Journal of Medicine 13:49-69, 1982

5. Protides of Biological Fluids 30:337-352, 1983

6. Protides of Biological Fluids 31:739-747, 1984

7. Cancer Detection and Prevention 8:Number 5/6, 551, 1985

8. Cancer Detection and Prevention 11:Number 1/2, 85, 1987

9. "In Vitro production of the general transformation antibody related to survival in human cancer patients: Antimalignin Antibody" Cancer Det. and Prev. 12:313-320, 1988

10. "Malignin antibody and early malignancy," the Lancet 337-977, 1991

11. "Malignin antibody returns to normal after successful treatment of breast cancer", Cancer Detection and Prevention 17(1):180, 1993

12. "Comparison of Antimalignin with other markers for early detection and surrogate endpoint use in chemoprevention trials for breast, colon, and prostate cancer," Journal of Cellular Biochemistry 19:61, 1994 (National Cancer Insitute Symposium)

13. "Early detection and monitoring of cancer with the Anti-Malignin Antibody Test," Cancer Detection and Prevention 18(1):65-78, 1994

14. "A checklist for suitability of biomarkers as surrogate endpoints in chemoprecention breast cancer," Journal of Cellular Biochemistry 19:172-185, 1993 (National Cancer Institute Symposium

15. "Aglyco pathology of viral receptors in dementias. In functional diversity of interacting receptors" New York Academy of Sciences 757:413-417, 1995

16. "Return of elevated antimalignin antibody to normal indicates remission of breast cancer" American Association for Cancer Research 37:486, 1996

17. "Antimalignin Antibody (AMAS) elevation detects persistent or recurrent breast cancer" Cancer Detection and Prevention 20(5):508-509, 1996

18. "A new era for cancer diagonsis and treatment based upon earlier, asympotmatic detection" Journal of Adv. Med. 10:149-150, 1997

19. "Production of a sythetic general cancer vaccine which augments the concentration of antimalignin antibody in vivo" Cancer Detection and Prevention 22(1):S-227, 1998

20. "A quantitive immune response in human cancer" Cancer Det. and Prev. 22(1)S-159, 1998

21. "Anti-malignin antibody in serum and other tumor marker determinations in breast cancer" Cancer Letters 148:39-48, 2000

22. "Hepatitis B and C virus-associated malignant transformation in human liver (viral 'safe haven') produces a cytotoxic antimalignin immune response" Cancer Det. and Prev. (1):S156, 2000

23. "Antimalignin antibody in serum elevation precedes CA125 elevation in ovarian cancer and PSA elevation in prostate cacner, with both fewer false negatives and false positives" Cancer Det. and Prev.

24(1): S-162, 2000 24 Cancer Detection and Prevention 26(1):S, 2002



 
We care about your thoughts!